Multiplikator Forward P/S Orgenesis Inc. (ORGS)
High adaptation costs for centers are constraining operational growth, which supports the future P/S of Orgenesis Inc. (ORGS). The value 15.10 serves as the current value for this metric's parameter. Orgenesis Inc. is implementing software for the local production of cell therapies to minimize logistical risks. Business scaling relies on cloud hosting and external integrators for the rapid deployment of systems within clinics.
Rincian analitis perusahaan Orgenesis Inc.
- rega pasar lan target rega analis:
- rincian kapitalisasi pasar:
- statistik nilai buku emiten:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal Orgenesis Inc.|ORGS - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Orgenesis Inc.|ORGS - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Orgenesis Corporation|ORGS - Kewajiban jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Orgenesis|Likuiditas cepet orgenesis.com
- data bathi bisnis lan rasio investasi:
ORGS - Penghasilan resik perusahaan|Bathi sing dikarepake Orgenesis Inc.|ORGS - Nilai perusahaan marang bathi resik|Pangali Forward P/E Orgenesis Corp|ORGS - Rasio rega marang wutah bathi resik|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Orgenesis Corporation|ORGS - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Orgenesis|ORGS - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan orgenesis.com|ORGS - Wutah bathi resik saben siji saham kanggo taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Orgenesis Inc.
- indikator volume dodolan lan pendapatan:
Pambiji fundamental perusahaan:Orgenesis ORGS
For the non-cyclical cell therapy business of Orgenesis Inc. (ORGS), the forward P/S multiple serves as an indicator of market expectations regarding revenue scaling rates. This ratio compares current market capitalization with projected sales volume, allowing investors to assess the premium paid for future growth and determine the fundamental capital stability of the issuer within the context of long-term medical planning.
Pesaing Orgenesis Inc. (ORGS)
Rasio rega marang prakiraan pendapatan Veeva VEEV|Rasio kapitalisasi marang dodolan sing dikarepake Doximity Inc (DOCS)|HealthEquity Corp - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Waystar Corp WAY|CorVel Corporation (CRVL) - Rasio rega marang prakiraan pendapatan|PRVA - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan HURN|CERT: Rega forward marang dodolan|Multiplikator Forward P/S OMCL|Rasio kapitalisasi marang dodolan sing dikarepake GoodRx Gold|Rasio rega marang prakiraan pendapatan Schrodinger, Inc. SDGR|PHR: Kapitalisasi marang prakiraan pendapatan|Omada Health - Multiplikator Forward P/S|Evolent Health Inc (EVH) - Multiplikator forward rega marang pendapatan|HSTM (HealthStream Corp) - Multiplikator forward rega marang pendapatan|DH - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Consensus Cloud Solutions|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep agilonhealth.com AGL|Rasio rega marang prakiraan pendapatan Absci Corporation (ABSI)|SY (So-Young International Inc) - Rega forward marang dodolan|Multiplikator Forward P/S NRC (National Research Corporation)|Prakiraan rega marang pendapatan USA Mobility|OPRX - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake trubridge.com TBRG|SLP: Multiplikator Forward P/S|SOPH - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan HCAT|CCLD (CareCloud Corp) - Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan RSSS (Research Solutions)|DLHC (dlhcorp.com) - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan OneMedNet ONMD|SCNX - Multiplikator forward rega marang pendapatan|Healthcare Triangle Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep iSpecimen Inc.|BFRG: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan WORX|Rasio rega marang prakiraan pendapatan MSP Recovery|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep iCoreConnect Corp ICCT|Rasio rega marang prakiraan pendapatan TRxADE (MEDS)|RCM (r1rcm.com) - Rega forward marang dodolan|Multiplikator Forward P/S SHCR (Sharecare, Inc.)|Prakiraan rega marang pendapatan streamlinehealth.net|Syra Health - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Apollo Medical Holdings|Model N Corp (MODN) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan NXGN
